外側上顆炎治療の世界市場

外側上顆炎治療の世界市場は2030年までに112億米ドルに達する見込み

2023年に95億米ドルと推定される外側上顆炎治療の世界市場は、2030年には112億米ドルに達し、分析期間2023-2030年のCAGRは2.5%で成長すると予測されます。本レポートで分析したセグメントの1つである非外科療法は、CAGR 2.9%を記録し、分析期間終了時には74億米ドルに達すると予測されます。外科的療法分野の成長率は、分析期間中CAGR 1.6％と推定されます。

米国市場は26億米ドルと推定、中国はCAGR 5.0％で成長予測

米国の外側上顆炎治療市場は2023年に26億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに22億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは5.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.6%と1.8%と予測されています。欧州では、ドイツがCAGR 1.2%で成長すると予測されています。

世界の外側上顆炎治療市場- 主要動向と促進要因まとめ

外側上顆炎とは何か、なぜ効果的な治療が重要なのか？

一般にテニス肘として知られる外側上顆炎は、肘の外側上顆に付着する腱の炎症や微小断裂に起因する痛みを伴う疾患です。この疾患は一般的に、前腕の筋肉の反復的なストレスや使い過ぎによって引き起こされ、肘の外側に痛みや圧痛が生じます。外側上顆炎は、スポーツ選手、特にテニスプレーヤーに多くみられますが、塗装工、大工、オフィスワーカーなど、手首や腕の運動を繰り返す人なら誰でも発症する可能性があります。この症状は、日常生活や仕事に関連した作業を行う能力に大きな影響を与える可能性があり、効果的な治療が非常に重要になります。外側上顆炎を治療せずに放置すると、慢性的な痛みや身体障害につながる可能性があり、早期介入の重要性が強調されています。この症状の根本的な原因とメカニズムを理解することは、症状を緩和するだけでなく、問題の根本原因に対処する効果的な治療戦略を開発するために不可欠です。

外側上顆炎の現在の治療法は？

外側上顆炎の治療には、痛みの軽減、治癒の促進、機能の回復を目的としたアプローチの組み合わせが含まれます。保存的治療が一般的に第一選択となり、安静、氷の使用、非ステロイド性抗炎症薬（NSAIDs）による疼痛と炎症の管理から始まります。理学療法は治療において重要な役割を果たし、患部の腱にかかる負担を軽減するために、前腕の筋肉のストレッチと強化エクササイズに重点を置く。緊張下で筋肉を伸ばすエキセントリックエクササイズは、腱の治癒を促進する上で特に有効であることが示されています。さらに、活動時の負担を軽減するために、リストスプリントやカウンターフォースブレースなどの装具がしばしば使用されます。保存的治療に反応しない患者には、副腎皮質ステロイド注射、多血小板血漿（PRP）療法、衝撃波療法など、より高度な治療が考慮されます。これらの介入は、炎症を抑えたり、腱レベルでの組織修復を促したりすることを目的としています。まれに、保存的治療や低侵襲的治療がうまくいかない場合には、腱のリリースや修復などの外科的治療が必要になることがあります。治療法の選択は、病態の重症度、患者の希望、初期治療に対する反応によって決まる。

外側上顆炎の治療はどのように進歩しているのでしょうか？

医療技術の革新と現在進行中の調査により、外側上顆炎の治療選択肢は絶えず進歩しており、難治性の患者さんや重症の患者さんに新たな希望をもたらしています。最も有望な研究分野のひとつが再生医療で、特に多血小板血漿（PRP）療法が注目されています。PRP療法では、患者自身の血小板を濃縮して患部に注入し、成長因子の放出によって治癒を促進します。この治療は、特に他の治療法に反応しなかった慢性症例において、痛みを軽減し、機能を改善するという有望な結果を示しています。もうひとつの革新的分野は、体外衝撃波治療（ESWT）の開発です。ESWTは音波を使って血流を刺激し、腱部位の組織修復を促進します。調査により、ESWTは慢性外側上顆炎の効果的な治療法であり、手術に代わる治療法であることが実証されています。さらに、ウェアラブル技術の進歩により、リハビリ運動中の筋活動や緊張に関するリアルタイムのフィードバックが提供され、外側上顆炎の管理が強化されつつあります。これらの技術革新は、治療効果を向上させるだけでなく、回復時間を短縮し、再発のリスクを最小限に抑えます。

外側上顆炎治療市場の成長を促進する要因とは？

外側上顆炎治療市場の成長は、技術の進歩、患者層の変化、ヘルスケアプラクティスの進化を反映したいくつかの要因によって牽引されています。主な要因の1つは、人口の高齢化や様々な職業における反復負荷損傷の発生率の上昇に伴い、外側上顆炎を含む筋骨格系障害の有病率が増加していることです。PRP療法やESWTのような低侵襲治療の開発などの技術的進歩は、患者が利用できる選択肢の幅を広げ、市場の成長に寄与しています。さらに、個別化医療への注目の高まりとデジタルヘルスツールの統合が、外側上顆炎の診断と管理を強化し、治療をより身近で効果的なものにしています。ヘルスケア支出の増加や、新興市場における高度な治療オプションの利用可能性の増加も、市場拡大を後押しする大きな要因となっています。さらに、患者とヘルスケア提供者双方の意識の高まりにより、早期診断と早期介入が重視されるようになり、効果的で革新的な治療に対する需要が高まっています。このような要因は、継続的な研究開発と相まって、今後も外側上顆炎治療市場の成長を牽引していくと予想されます。

調査対象企業の例（全52件）

• 3M Company
• Aksigen Hospital Care
• Beurer GmbH
• BioMedical Life Systems, Inc.
• BTL Industries
• EMS Physio Ltd.
• Johari Digital Healthcare Ltd.
• OMRON Healthcare Co., Ltd.
• Ossur hf.
• Ottobock SE & Co. KGaA
• Seikagaku Corporation
• Teikoku Pharma USA
• Zimmer Biomet Holdings, Inc.
• Zynex, Inc.;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Lateral Epicondylitis Treatment Market to Reach US$11.2 Billion by 2030

The global market for Lateral Epicondylitis Treatment estimated at US$9.5 Billion in the year 2023, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 2.5% over the analysis period 2023-2030. Non-Surgical Therapies, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Surgical Therapies segment is estimated at 1.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 5.0% CAGR

The Lateral Epicondylitis Treatment market in the U.S. is estimated at US$2.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Lateral Epicondylitis Treatment Market - Key Trends and Drivers Summarized

What Is Lateral Epicondylitis and Why Is Effective Treatment Crucial?

Lateral epicondylitis, commonly known as tennis elbow, is a painful condition resulting from inflammation or microtearing of the tendons that attach to the lateral epicondyle of the elbow. This condition is typically caused by repetitive stress or overuse of the forearm muscles, leading to pain and tenderness on the outer part of the elbow. While it is often associated with athletes, particularly tennis players, lateral epicondylitis can affect anyone who engages in repetitive wrist and arm motions, such as painters, carpenters, or office workers. The condition can significantly impact a person’s ability to perform daily activities and work-related tasks, making effective treatment crucial. Left untreated, lateral epicondylitis can lead to chronic pain and disability, underscoring the importance of early intervention. Understanding the underlying causes and mechanisms of this condition is essential for developing effective treatment strategies that not only alleviate symptoms but also address the root cause of the problem.

What Are the Current Treatment Options for Lateral Epicondylitis?

The treatment of lateral epicondylitis involves a combination of approaches aimed at reducing pain, promoting healing, and restoring function. Conservative treatment is typically the first line of defense, starting with rest, ice application, and nonsteroidal anti-inflammatory drugs (NSAIDs) to manage pain and inflammation. Physical therapy plays a crucial role in treatment, focusing on stretching and strengthening exercises for the forearm muscles to alleviate strain on the affected tendons. Eccentric exercises, where the muscle lengthens under tension, have shown particular efficacy in promoting tendon healing. Additionally, orthotic devices such as wrist splints or counterforce braces are often used to reduce strain during activities. For patients who do not respond to conservative measures, more advanced treatments like corticosteroid injections, platelet-rich plasma (PRP) therapy, or shockwave therapy may be considered. These interventions aim to reduce inflammation or stimulate tissue repair at the tendon level. In rare cases, when conservative and minimally invasive treatments fail, surgical options such as tendon release or repair may be necessary. The choice of treatment depends on the severity of the condition, patient preferences, and the response to initial therapies.

How Are Innovations and Research Advancing the Treatment of Lateral Epicondylitis?

Innovations in medical technology and ongoing research are continuously advancing the treatment options for lateral epicondylitis, offering new hope for patients with persistent or severe cases. One of the most promising areas of research is regenerative medicine, particularly the use of platelet-rich plasma (PRP) therapy. PRP involves injecting a concentrated dose of the patient’s own platelets into the affected area to promote healing through the release of growth factors. This treatment has shown encouraging results in reducing pain and improving function, particularly in chronic cases that have not responded to other therapies. Another area of innovation is the development of extracorporeal shockwave therapy (ESWT), which uses sound waves to stimulate blood flow and promote tissue repair at the tendon site. Research has demonstrated that ESWT can be an effective treatment for chronic lateral epicondylitis, offering an alternative to surgery. Additionally, advancements in wearable technology are enhancing the management of lateral epicondylitis by providing real-time feedback on muscle activity and strain during rehabilitation exercises. These innovations are not only improving the effectiveness of treatment but also reducing recovery times and minimizing the risk of recurrence.

What Factors Are Driving Growth in the Lateral Epicondylitis Treatment Market?

The growth in the lateral epicondylitis treatment market is driven by several factors that reflect technological advancements, changing patient demographics, and evolving healthcare practices. One of the primary drivers is the increasing prevalence of musculoskeletal disorders, including lateral epicondylitis, as a result of aging populations and the rising incidence of repetitive strain injuries in various professions. Technological advancements, such as the development of minimally invasive treatments like PRP therapy and ESWT, have expanded the range of options available to patients and are contributing to the market's growth. Additionally, the growing focus on personalized medicine and the integration of digital health tools are enhancing the diagnosis and management of lateral epicondylitis, making treatments more accessible and effective. The rise in healthcare expenditure and the increasing availability of advanced treatment options in emerging markets are also significant factors fueling market expansion. Furthermore, the emphasis on early diagnosis and intervention, driven by increased awareness among both patients and healthcare providers, is boosting demand for effective and innovative treatments. These factors, combined with ongoing research and development, are expected to continue driving growth in the lateral epicondylitis treatment market.

Select Competitors (Total 52 Featured) -

• 3M Company
• Aksigen Hospital Care
• Beurer GmbH
• BioMedical Life Systems, Inc.
• BTL Industries
• EMS Physio Ltd.
• Johari Digital Healthcare Ltd.
• OMRON Healthcare Co., Ltd.
• Ossur hf.
• Ottobock SE & Co. KGaA
• Seikagaku Corporation
• Teikoku Pharma USA
• Zimmer Biomet Holdings, Inc.
• Zynex, Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Lateral Epicondylitis Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Sports-Related Injuries Expands Addressable Market Opportunity for Lateral Epicondylitis Treatments
  • Advancements in Non-Surgical Therapies Propel Growth in Conservative Treatment Options for Lateral Epicondylitis
  • Increasing Adoption of Minimally Invasive Procedures Drives Demand for Innovative Lateral Epicondylitis Treatments
  • Integration of Biologic and Regenerative Medicine Throws the Spotlight on Novel Treatment Modalities for Tendon Repair
  • Emergence of Wearable and Assistive Technologies Expands Market Scope for Rehabilitation and Prevention of Lateral Epicondylitis
  • Rising Geriatric Population and Associated Tendon Degeneration Generate Demand for Long-Term Management Solutions
  • Challenges in Treatment Efficacy and Recurrence Rates Present Opportunities for Innovation in Therapeutic Approaches
  • Expansion of Sports Medicine Clinics and Physical Therapy Centers Creates New Opportunities for Lateral Epicondylitis Treatment Adoption
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Lateral Epicondylitis Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Lateral Epicondylitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Non-Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Non-Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Non-Surgical Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Surgical Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pharma & Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Pharma & Drug Stores End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 17: USA Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 18: USA Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: USA 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 20: USA Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 23: Canada Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: Canada Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: Canada 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• JAPAN
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 29: Japan Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Japan Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Japan 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• CHINA
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 35: China Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: China Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: China 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 38: China Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: China 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• EUROPE
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 41: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 42: Europe Historic Review for Lateral Epicondylitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• FRANCE
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 50: France Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: France Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: France 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 53: France Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: France 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• GERMANY
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 56: Germany Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Germany Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Germany 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 62: Italy Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Italy Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Italy 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 68: UK Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: UK Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: UK 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 71: UK Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 74: Spain Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Spain Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Spain 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 77: Spain Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Spain Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Spain 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 80: Russia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Russia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Russia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 83: Russia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Russia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Russia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 101: Australia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Australia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Australia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 104: Australia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Australia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Australia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• INDIA
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 107: India Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: India Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: India 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 110: India Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: India Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: India 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 113: South Korea Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: South Korea Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: South Korea 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 116: South Korea Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: South Korea Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 118: South Korea 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Rest of Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Rest of Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 125: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 126: Latin America Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 127: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 128: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Latin America Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 130: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 133: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 134: Argentina Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Argentina Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 136: Argentina 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 137: Argentina Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Argentina Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 139: Argentina 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 140: Brazil Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Brazil Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 142: Brazil 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 143: Brazil Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Brazil Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 145: Brazil 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 146: Mexico Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Mexico Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 148: Mexico 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 149: Mexico Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Mexico Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 151: Mexico 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Rest of Latin America Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 154: Rest of Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Rest of Latin America Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 157: Rest of Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 158: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 159: Middle East Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 160: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 161: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Middle East Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 163: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 166: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 167: Iran Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 168: Iran Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 169: Iran 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 170: Iran Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 171: Iran Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 172: Iran 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 173: Israel Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 174: Israel Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 175: Israel 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 176: Israel Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 177: Israel Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 178: Israel 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 180: Saudi Arabia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 181: Saudi Arabia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Saudi Arabia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 184: Saudi Arabia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 185: UAE Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 186: UAE Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 187: UAE 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 188: UAE Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 189: UAE Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 190: UAE 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 192: Rest of Middle East Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 193: Rest of Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Rest of Middle East Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 196: Rest of Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
• AFRICA
  • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 197: Africa Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Africa Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 199: Africa 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
  • TABLE 200: Africa Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Africa Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 202: Africa 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION